These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16862720)

  • 1. Court filing makes public my previously suppressed analysis of Paxil's effects.
    Breggin PR
    Ethical Hum Psychol Psychiatry; 2006; 8(1):77-84. PubMed ID: 16862720
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants and children. Buried data can be hazardous to a company's health.
    Marshall E
    Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
    [No Abstract]   [Full Text] [Related]  

  • 3. Causality and collateral estoppel: process and content of recent SSRI litigation.
    Whitehead PD
    J Am Acad Psychiatry Law; 2003; 31(3):377-82. PubMed ID: 14584540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A question of balance.
    Ramchandani P
    Nature; 2004 Jul; 430(6998):401-2. PubMed ID: 15269742
    [No Abstract]   [Full Text] [Related]  

  • 5. Suicide attempts in clinical trials with paroxetine randomised against placebo.
    Aursnes I; Tvete IF; Gaasemyr J; Natvig B
    BMC Med; 2005 Aug; 3():14. PubMed ID: 16115311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressing misrepresentation?
    Newton J; Langlands A
    Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640
    [No Abstract]   [Full Text] [Related]  

  • 7. On the origin of great ideas: science in the age of big pharma.
    McHenry L
    Hastings Cent Rep; 2005; 35(6):17-9. PubMed ID: 16396201
    [No Abstract]   [Full Text] [Related]  

  • 8. The whole truth: drug companies must tell us all they know about the medicines we take.
    New Sci; 2004 May 1-7; 182(2445):3. PubMed ID: 15278970
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry-sponsored ghostwriting in clinical trial reporting: a case study.
    McHenry LB; Jureidini JN
    Account Res; 2008; 15(3):152-67. PubMed ID: 18792536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions.
    Healy D
    West J Med; 2001 Dec; 175(6):364. PubMed ID: 11733415
    [No Abstract]   [Full Text] [Related]  

  • 11. Reputations at stake.
    New Sci; 2002 Mar; 173(2334):16. PubMed ID: 12408135
    [No Abstract]   [Full Text] [Related]  

  • 12. Is GSK guilty of fraud?
    Lancet
    Lancet; 2004 Jun; 363(9425):1919. PubMed ID: 15194246
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief report: paroxetine in younger and adult individuals at high risk for suicide.
    Bauer MS; Wisniewski SR; Kogan JN; Marangell LB; Thase ME; Sachs G
    Psychopharmacol Bull; 2006; 39(1):31-7. PubMed ID: 17065973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of child and adolescent depression: a matter of concern?
    Thomsen PH
    Acta Psychiatr Scand; 2007 Mar; 115(3):169-70. PubMed ID: 17302616
    [No Abstract]   [Full Text] [Related]  

  • 15. Judge might reopen GSK paroxetine case.
    Dyer C
    BMJ; 2016 Feb; 352():i800. PubMed ID: 26858261
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoxetine-induced suicidal ideation: an examination of the medical literature, case law, and the legal liability of drug manufacturers.
    Falsetti AE
    Food Drug Law J; 2002; 57(2):247-67. PubMed ID: 12436991
    [No Abstract]   [Full Text] [Related]  

  • 18. Lawyers may seek judicial review of panel reviewing paroxetine.
    Dobson R
    BMJ; 2003 Mar; 326(7390):618. PubMed ID: 12649225
    [No Abstract]   [Full Text] [Related]  

  • 19. The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study.
    Parabiaghi A; Franchi C; Tettamanti M; Barbato A; D'Avanzo B; Fortino I; Bortolotti A; Merlino L; Nobili A
    J Clin Psychopharmacol; 2012 Apr; 32(2):303-5. PubMed ID: 22388169
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.